Welcome to our store!
New collections added on a weekly basis!
Now Accepting FSA & HSA cards
for all orders over $99.99 within the CONTINENTAL USA.
Background: Early in the COVID-19 pandemic, clinicians were looking for practical, widely available, and low-cost interventions to help patients with hypoxemia. One of those interventions was awake prone positioning. Potential...
Marco Torres |
Background: The effects of the COVID-19 pandemic have been devastating. Given the novelty of the virus, only a few effective treatments have emerged to decrease mortality from SARS-CoV-2 infection. The...
Marco Torres |
Background: COVID-19 infection increases the risk of thrombosis due to multiple factors.(Rico-Mesa, 2020). Over the last 2 years, researchers have published 12 RCTs investigating various anticoagulation strategies among patients diagnosed with...
Marco Torres |
Background: COVID-19 became an international pandemic in March of 2020, claiming the lives of millions of people worldwide. To combat this deadly virus, an unprecedented global effort led to the...
Marco Torres |
Background: Patients hospitalized with COVID-19 are at increased risk for both arterial and venous thromboembolic disease. Multiple recent trials have investigated the efficacy of therapeutic or standard prophylactic anticoagulation in...
Marco Torres |
Background: Patients diagnosed with COVID-19 have an increased risk of thromboembolic events, including pulmonary embolism and deep vein thrombosis (DVT). In addition, COVID-19 patients with increased coagulation parameters such as...
Marco Torres |
Background: On December 23, 2021, the FDA granted molnupiravir emergency use authorization for the treatment of patients with Covid-19. Molnupiravir is a nucleoside analog that inhibits SARS-CoV-2 replication and triggers...
Marco Torres |
Background: Severely ill patients diagnosed with COVID-19 have an increased risk of cardiovascular complications, especially thromboembolic events (Bikdeli 2020). The overall incidence of developing venous thromboembolism (VTE) is approximately 17%...
Marco Torres |
Background: Despite access to vaccines in developed countries, COVID19 remains a nimble and persistent foe. While case counts wax and wane the virus continues to spread and mutate. The rapid...
Marco Torres |
I was fortunate enough to record a podcast on Rob Orman’s, Stimulus podcast on Oct 14th, 2021. We both felt it was an important enough topic that we should post...
Marco Torres |
A previously healthy 8-year-old female presents to the pediatric emergency department due to a rash. Her symptoms started three days prior to presentation with a painful rash on her lower...
Kate Alemann, MD |
Background: Since the beginning of the pandemic, hundreds of trials have been performed looking at medications with the potential to be repurposed for use against COVID19. To date, no antiviral...
Marco Torres |
In July 2021, Dr. Vivek Murthy became the first U.S. Surgeon General to declare health misinformation a public health crisis. Specifically, COVID-19 vaccine misinformation and disinformation on social media greatly...
Michael Gisondi, MD |
Su carrito
Visit our support center
Expert help & advice
Check your order status
Updates & tracking
Returns & exchanges
All you need to know
Everyday Low Prices
No need to wait for a "sale"
Elegir opciones